These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7728402)

  • 1. The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view.
    Ehrenstein MR; Conroy SE; Heath J; Latchman DS; Isenberg DA
    Br J Rheumatol; 1995 Mar; 34(3):257-60. PubMed ID: 7728402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.
    Petri M; Genovese M; Engle E; Hochberg M
    Arthritis Rheum; 1991 Aug; 34(8):937-44. PubMed ID: 1859487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study.
    Petri M; Singh S; Tesfasyone H; Malik A
    J Rheumatol; 2009 Nov; 36(11):2476-80. PubMed ID: 19833757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study.
    Piga M; Gabba A; Congia M; Figus F; Cauli A; Mathieu A
    Semin Arthritis Rheum; 2016 Oct; 46(2):217-224. PubMed ID: 27238877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
    Posalski JD; Ishimori Ml; Wallace DJ; Weisman MH
    Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
    Ho A; Magder LS; Barr SG; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus.
    Brunner HI; Holland M; Beresford MW; Ardoin SP; Appenzeller S; Silva CA; Flores F; Goilav B; Wenderfer SE; Levy DM; Ravelli A; Khunchandani R; Avcin T; Klein-Gitelman MS; Feldman BM; Ruperto N; Ying J;
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):813-822. PubMed ID: 29693328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flares in patients with systemic lupus erythematosus.
    McElhone K; Abbott J; Hurley M; Burnell J; Lanyon P; Rahman A; Yee CS; Akil M; Bruce IN; Ahmad Y; Gordon C; Teh LS
    Rheumatology (Oxford); 2021 Jul; 60(7):3262-3267. PubMed ID: 33325488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP; Manson JJ; Rahman A; Isenberg DA
    Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and risk factors for lupus flares in sub-Saharan Africa-retrospective cross-sectional study.
    Legesse BA; Adugna BA; Ayalew ZS; Azibte GT; Abdulkadir SI; Mengist BA; Zewde DA; Kassa AZ; Abera BM; Gudetta AB
    Clin Rheumatol; 2024 Sep; 43(9):2867-2875. PubMed ID: 39090484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
    Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
    Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surge in anti-dsDNA titer predicts a severe lupus flare within six months.
    Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA
    Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies.
    Ruiz-Irastorza G; Lima F; Alves J; Khamashta MA; Simpson J; Hughes GR; Buchanan NM
    Br J Rheumatol; 1996 Feb; 35(2):133-8. PubMed ID: 8612024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER).
    Merrill J; Buyon J; Furie R; Latinis K; Gordon C; Hsieh HJ; Brunetta P
    Lupus; 2011 Jun; 20(7):709-16. PubMed ID: 21478286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of systemic lupus erythematosus expression in Europe.
    Cervera R; Doria A; Amoura Z; Khamashta M; Schneider M; Guillemin F; Maurel F; Garofano A; Roset M; Perna A; Murray M; Schmitt C; Boucot I
    Autoimmun Rev; 2014 Jun; 13(6):621-9. PubMed ID: 24418306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
    Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
    Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal variations of systemic lupus erythematosus flares in southern France.
    Chiche L; Jourde N; Ulmann C; Mancini J; Darque A; Bardin N; Dicostanzo MP; Thomas G; Harlé JR; Vienne J; Loukos H; Bornet C
    Eur J Intern Med; 2012 Apr; 23(3):250-4. PubMed ID: 22385883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.